YA II PN, Ltd. 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-08 2:11 pm Purchase |
2025-06-16 | 13G | Aptevo Therapeutics Inc. APVO |
YA II PN, Ltd. | 357,842 9.990% |
357,842 (New Position) |
Filing |